Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vandana Sachdev

Showing results (41-50 of 114) with videos related to

Pageof 12
Sort By:
The Journal of Clinical Endocrinology and Metabolism|August 26, 2011
Metabolic effects of liothyronine therapy in hypothyroidism: a randomized, double-blind, crossover trial of liothyronine versus levothyroxineFrancesco S Celi, Marina Zemskova, Joyce D Linderman, et al.
British Journal of Haematology|January 28, 2021
A phenotypic risk score for predicting mortality in sickle cell diseaseVandana Sachdev, Xin Tian, Yuan Gu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2006
Cardiac studies in patients treated with depsipeptide, FK228, in a phase II trial for T-cell lymphomaRichard L Piekarz, A Robin Frye, John J Wright, et al.
American Heart Journal|July 2, 2005
Left atrial volumetric remodeling is predictive of functional capacity in nonobstructive hypertrophic cardiomyopathyVandana Sachdev, Yukitaka Shizukuda, Cynthia L Brenneman, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|September 16, 2022
Increased Susceptibility for Adverse Reactions to Ultrasound Enhancing Agents in Sickle Cell DiseaseMelinda Wu, Joshua J Fields, Vandana Sachdev, et al.
Journal of Cardiac Failure|February 19, 2022
Ascertaining Death Events in a Pragmatic Clinical Trial: Insights From the TRANSFORM-HF TrialEric L Eisenstein, Shelly Sapp, Tina Harding, et al.
British Journal of Haematology|October 23, 2024
A machine learning-based workflow for predicting transplant outcomes in patients with sickle cell diseaseHaiou Li, Vandana Sachdev, Xin Tian, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 10, 2018
Low-dose, short course alteplase treatment of submassive pulmonary embolism: a case series from the National Institutes of Health Clinical CenterJay N Lozier, Jason M Elinoff, Anthony F Suffredini, et al.
Haematologica|November 22, 2015
Elevated transpulmonary gradient and cardiac magnetic resonance-derived right ventricular remodeling predict poor outcomes in sickle cell diseaseKim-Lien Nguyen, Xin Tian, Shoaib Alam, et al.
American Journal of Hematology|August 29, 2007
Mutations and polymorphisms in hemoglobin genes and the risk of pulmonary hypertension and death in sickle cell diseaseJames G Taylor, Diana Ackah, Crystal Cobb, et al.
Pageof 12

Showing results (41-50 of 114) with videos related to

Sort By:
Pageof 12
The Journal of Clinical Endocrinology and Metabolism|August 26, 2011
Metabolic effects of liothyronine therapy in hypothyroidism: a randomized, double-blind, crossover trial of liothyronine versus levothyroxineFrancesco S Celi, Marina Zemskova, Joyce D Linderman, et al.
British Journal of Haematology|January 28, 2021
A phenotypic risk score for predicting mortality in sickle cell diseaseVandana Sachdev, Xin Tian, Yuan Gu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2006
Cardiac studies in patients treated with depsipeptide, FK228, in a phase II trial for T-cell lymphomaRichard L Piekarz, A Robin Frye, John J Wright, et al.
American Heart Journal|July 2, 2005
Left atrial volumetric remodeling is predictive of functional capacity in nonobstructive hypertrophic cardiomyopathyVandana Sachdev, Yukitaka Shizukuda, Cynthia L Brenneman, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|September 16, 2022
Increased Susceptibility for Adverse Reactions to Ultrasound Enhancing Agents in Sickle Cell DiseaseMelinda Wu, Joshua J Fields, Vandana Sachdev, et al.
Journal of Cardiac Failure|February 19, 2022
Ascertaining Death Events in a Pragmatic Clinical Trial: Insights From the TRANSFORM-HF TrialEric L Eisenstein, Shelly Sapp, Tina Harding, et al.
British Journal of Haematology|October 23, 2024
A machine learning-based workflow for predicting transplant outcomes in patients with sickle cell diseaseHaiou Li, Vandana Sachdev, Xin Tian, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 10, 2018
Low-dose, short course alteplase treatment of submassive pulmonary embolism: a case series from the National Institutes of Health Clinical CenterJay N Lozier, Jason M Elinoff, Anthony F Suffredini, et al.
Haematologica|November 22, 2015
Elevated transpulmonary gradient and cardiac magnetic resonance-derived right ventricular remodeling predict poor outcomes in sickle cell diseaseKim-Lien Nguyen, Xin Tian, Shoaib Alam, et al.
American Journal of Hematology|August 29, 2007
Mutations and polymorphisms in hemoglobin genes and the risk of pulmonary hypertension and death in sickle cell diseaseJames G Taylor, Diana Ackah, Crystal Cobb, et al.
Pageof 12